| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |